Head to Head Contrast: West Pharmaceutical Services (NYSE:WST) and Scripsamerica (OTCMKTS:SCRCQ)

Scripsamerica (OTCMKTS:SCRCQGet Free Report) and West Pharmaceutical Services (NYSE:WSTGet Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations.

Profitability

This table compares Scripsamerica and West Pharmaceutical Services’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Scripsamerica N/A N/A N/A
West Pharmaceutical Services 16.29% 18.16% 13.45%

Earnings & Valuation

This table compares Scripsamerica and West Pharmaceutical Services”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Scripsamerica N/A N/A N/A N/A N/A
West Pharmaceutical Services $2.89 billion 6.83 $492.70 million $6.75 40.70

West Pharmaceutical Services has higher revenue and earnings than Scripsamerica.

Insider and Institutional Ownership

93.9% of West Pharmaceutical Services shares are owned by institutional investors. 0.5% of West Pharmaceutical Services shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations for Scripsamerica and West Pharmaceutical Services, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Scripsamerica 0 0 0 0 0.00
West Pharmaceutical Services 0 4 8 2 2.86

West Pharmaceutical Services has a consensus price target of $342.20, suggesting a potential upside of 24.57%. Given West Pharmaceutical Services’ stronger consensus rating and higher probable upside, analysts plainly believe West Pharmaceutical Services is more favorable than Scripsamerica.

Summary

West Pharmaceutical Services beats Scripsamerica on 10 of the 10 factors compared between the two stocks.

About Scripsamerica

(Get Free Report)

ScripsAmerica, Inc. develops and sells non-sterile topical and transdermal pain creams. The company also provides pharmacy dispensing services for individual doctors, as well as billing and administrative services to independent pharmacies. In addition, it distributes pharmaceutical products to independent pharmacies and other medical providers. The company was founded in 2008 and is based in Clifton, New Jersey. On February 8, 2017, the voluntary petition of ScripsAmerica, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 7, 2016.

About West Pharmaceutical Services

(Get Free Report)

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Receive News & Ratings for Scripsamerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scripsamerica and related companies with MarketBeat.com's FREE daily email newsletter.